More progress defining the crosstalk between multiple myeloma and mesenchymal stem cells of the bone marrow.
Gregory
Carl A
CA
Department of Medicine, Center for Gene Therapy, Tulane Health Sciences Center, Tulane University, New Orleans, Louisiana, USA. cgregory@tulane.edu
D001854:Bone Marrow Cells / Q000276:immunology / Q000378:metabolism*; D001842:Bone and Bones / Q000378:metabolism; D002454:Cell Differentiation; D049109:Cell Proliferation; D018450:Disease Progression; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D008648:Mesoderm / Q000276:immunology / Q000378:metabolism*; D008954:Models, Biological; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy*; D010006:Osteoblasts / Q000378:metabolism; D015398:Signal Transduction; D013234:Stem Cells / Q000276:immunology / Q000378:metabolism*; D013601:T-Lymphocytes / Q000378:metabolism; D051153:Wnt Proteins / Q000378:metabolism
D015850:Interleukin-6; D051153:Wnt Proteins